Terminology Service for NFDI4Health
JSON

CVD IL-2/IFNa2b Regimen

Go to external page http://purl.obolibrary.org/obo/NCIT_C63785

A regimen consisting of cisplatin, vinblastine, dacarbazine, interleukin-2 (IL-2) and interferon alfa-2b (IFNa2b) that can be used for the treatment of melanoma. [ ]

Term info

Label

CVD IL-2/IFNa2b Regimen

Synonyms
  • CVD IL-2-IFNa2b
  • CVD IL-2/IFNa2b Regimen
  • CVD/IL-2/IFNa2b
  • Cisplatin-Vinblastine-Dacarbazine Aldesleukin-Interferon alpha-2b Regimen
  • Cisplatin-Vinblastine-Dacarbazine-Aldesleukin-Interferon alfa-2b
  • Cisplatin/Vinblastine/Dacarbazine/Aldesleukin/Interferon alfa-2b
  • Cisplatin/Vinblastine/Dacarbazine/Interleukin-2/Interferon alfa-2b
  • Dacarbazine/Cisplatin/Vinblastine/IL-2/IFNa2b
  • Dacarbazine/Cisplatin/Vinblastine/Interleukin-2/Interferon alfa-2b
Subsets

NCIT_C160952, NCIT_C160950

DesignNote

Source: NCCN Guidelines for 2018

Legacy Concept Name

CVD-IL_2-IFN_Regimen

Preferred Name

CVD IL-2/IFNa2b Regimen

Semantic Type

Therapeutic or Preventive Procedure

UMLS CUI

C1879977

code

C63785